The Expanding Role of MT1-MMP in Cancer Progression

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2019 May 30

PMID 31137480

Citations 33

Authors

Anna M Knapinska

Gregg B Fields

Affiliations

Soon will be listed here.

Abstract

For over 20 years, membrane type 1 matrix metalloproteinase (MT1-MMP) has been recognized as a key component in cancer progression. Initially, the primary roles assigned to MT1-MMP were the activation of proMMP-2 and degradation of fibrillar collagen. Proteomics has revealed a great array of MT1-MMP substrates, and MT1-MMP selective inhibitors have allowed for a more complete mapping of MT1-MMP biological functions. MT1-MMP has extensive sheddase activities, is both a positive and negative regulator of angiogenesis, can act intracellularly and as a transcription factor, and modulates immune responses. We presently examine the multi-faceted role of MT1-MMP in cancer, with a consideration of how the diversity of MT1-MMP behaviors impacts the application of MT1-MMP inhibitors.

Citing Articles

[High expression of the stemness-associated molecule Nanog in esophageal squamous cell carcinoma tissues promotes tumor invasion and metastasis by activating the TGF-β signaling pathway].

Sun C, Zheng S, Li M, Yang M, Qin M, Xu Y Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(6):1209-1216.

PMID: 38977352 PMC: 11237290. DOI: 10.12122/j.issn.1673-4254.2024.06.23.

Unveiling the power of flavonoids: A dynamic exploration of their impact on cancer through matrix metalloproteinases regulation.

Rajendran P Biomedicine (Taipei). 2024; 14(2):12-28.

PMID: 38939095 PMC: 11204124. DOI: 10.37796/2211-8039.1447.

Recent insights into the therapeutic strategies targeting the pseudokinase PTK7 in cancer.

Dessaux C, Ganier L, Guiraud L, Borg J Oncogene. 2024; 43(26):1973-1984.

PMID: 38773263 PMC: 11196218. DOI: 10.1038/s41388-024-03060-x.

Bioinformatics analysis of MMP14+ myeloid cells affecting endothelial-mesenchymal transformation and immune microenvironment in glioma.

Luo W, Quan Q, Xu Z, Lei J, Peng R Heliyon. 2024; 10(5):e26859.

PMID: 38434278 PMC: 10904238. DOI: 10.1016/j.heliyon.2024.e26859.

Molecular Insight into Gastric Cancer Invasion-Current Status and Future Directions.

Matsuoka T, Yashiro M Cancers (Basel). 2024; 16(1).

PMID: 38201481 PMC: 10778111. DOI: 10.3390/cancers16010054.

References

Zhou Z, Apte S, Soininen R, Cao R, Baaklini G, Rauser R . Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci U S A. 2000; 97(8):4052-7. PMC: 18145. DOI: 10.1073/pnas.060037197. View

Hotary K, Allen E, Punturieri A, Yana I, Weiss S . Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol. 2000; 149(6):1309-23. PMC: 2175112. DOI: 10.1083/jcb.149.6.1309. View

Lee M, Alpaugh M, Nguyen M, Deato M, Dishakjian L, Barsky S . Myoepithelial-specific CD44 shedding is mediated by a putative chymotrypsin-like sheddase. Biochem Biophys Res Commun. 2000; 279(1):116-23. DOI: 10.1006/bbrc.2000.3918. View

Belkin A, Akimov S, Zaritskaya L, Ratnikov B, Deryugina E, Strongin A . Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J Biol Chem. 2001; 276(21):18415-22. DOI: 10.1074/jbc.M010135200. View

Ellerbroek S, Wu Y, Overall C, Stack M . Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. J Biol Chem. 2001; 276(27):24833-42. DOI: 10.1074/jbc.M005631200. View

Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H . Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol. 2001; 153(5):893-904. PMC: 2174329. DOI: 10.1083/jcb.153.5.893. View

Gingras D, Langlois S, Lachambre M, Annabi B, Beliveau R . Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP). FEBS Lett. 2001; 507(2):231-6. DOI: 10.1016/s0014-5793(01)02985-4. View

Deryugina E, Ratnikov B, Postnova T, Rozanov D, Strongin A . Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J Biol Chem. 2001; 277(12):9749-56. DOI: 10.1074/jbc.M110269200. View

Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H . CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J. 2002; 21(15):3949-59. PMC: 126155. DOI: 10.1093/emboj/cdf411. View

10.

Koike T, Vernon R, Hamner M, Sadoun E, Reed M . MT1-MMP, but not secreted MMPs, influences the migration of human microvascular endothelial cells in 3-dimensional collagen gels. J Cell Biochem. 2002; 86(4):748-58. DOI: 10.1002/jcb.10257. View

11.

Karsdal M, Larsen L, Engsig M, Lou H, Ferreras M, Lochter A . Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J Biol Chem. 2002; 277(46):44061-7. DOI: 10.1074/jbc.M207205200. View

12.

Galvez B, Matias-Roman S, Yanez-Mo M, Sanchez-Madrid F, Arroyo A . ECM regulates MT1-MMP localization with beta1 or alphavbeta3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells. J Cell Biol. 2002; 159(3):509-21. PMC: 2173082. DOI: 10.1083/jcb.200205026. View

13.

Endo K, Takino T, Miyamori H, Kinsen H, Yoshizaki T, Furukawa M . Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J Biol Chem. 2003; 278(42):40764-70. DOI: 10.1074/jbc.M306736200. View

14.

Emonard H, Remacle A, Noel A, Grimaud J, Stetler-Stevenson W, Foidart J . Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenase. Cancer Res. 1992; 52(20):5845-8. View

15.

Rozanov D, Hahn-Dantona E, Strickland D, Strongin A . The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells. J Biol Chem. 2003; 279(6):4260-8. DOI: 10.1074/jbc.M311569200. View

16.

Wu Y, Munshi H, Sen R, Snipas S, Salvesen G, Fridman R . Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase. J Biol Chem. 2003; 279(9):8278-89. DOI: 10.1074/jbc.M311870200. View

17.

Cao J, Kozarekar P, Pavlaki M, Chiarelli C, Bahou W, Zucker S . Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration. J Biol Chem. 2004; 279(14):14129-39. DOI: 10.1074/jbc.M312120200. View

18.

Sounni N, Roghi C, Chabottaux V, Janssen M, Munaut C, Maquoi E . Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases. J Biol Chem. 2004; 279(14):13564-74. DOI: 10.1074/jbc.M307688200. View

19.

Nakamura H, Suenaga N, Taniwaki K, Matsuki H, Yonezawa K, Fujii M . Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase. Cancer Res. 2004; 64(3):876-82. DOI: 10.1158/0008-5472.can-03-3502. View

20.

Iida J, Wilhelmson K, Price M, Wilson C, Pei D, Furcht L . Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth. J Invest Dermatol. 2004; 122(1):167-76. DOI: 10.1046/j.0022-202X.2003.22114.x. View